A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G → a mutation in the factor V gene

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 2, 2002, Pages 117-122

  Hung, K ^a   Sun, X ^a   Ding, H ^a   Kalafatis, Michael ^a   Simioni, P ^a   Guo, B ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

APC resistance; Factor V; Genotyping; Mass spectrometry; Thrombosis

Indexed keywords

2',3' DIDEOXYADENOSINE TRIPHOSPHATE; 2',3' DIDEOXYCYTIDINE 5' TRIPHOSPHATE; 2',3' DIDEOXYTHYMIDINE TRIPHOSPHATE; ARGININE; BLOOD CLOTTING FACTOR 5; DEOXYGUANOSINE TRIPHOSPHATE; DNA BASE; GENOMIC DNA; GLUTAMINE; NUCLEOTIDE; PRIMER DNA; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACCURACY; ACTIVATED PROTEIN C RESISTANCE; ALLELE; AMINO ACID SUBSTITUTION; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POINT MUTATION; PRIORITY JOURNAL; THROMBOPHILIA; CASE CONTROL STUDY; COMPARATIVE STUDY; FAMILY HEALTH; GENETICS; MASS SPECTROMETRY; METHODOLOGY; REPRODUCIBILITY; STANDARD;

ACTIVATED PROTEIN C RESISTANCE; CASE-CONTROL STUDIES; FACTOR V; FAMILY HEALTH; GENETIC SCREENING; GENOTYPE; HUMANS; POINT MUTATION; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0036489807     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200203000-00006     Document Type: Article

References (29)

1. Leiden and thrombophilia
2. The mechanism of inactivation of human factor V and human factor Va by activated protein C
3. Familial thrombophilia due to a previously unrecognized mechanism by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
4. Mutation in blood coagulation factor V associated with resistance to activated protein C
5. R506Q
6. Increased tissue factor initiated prothrombin activation as a result of the Arg506Gln mutation in factor V Leiden
7. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
8. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
9. Leiden using a 5′ nuclease assay
10. Simple and rapid detection of factor V Leiden by allele specific PCR amplification
11. A colorimetric minisequencing assay for the mutation in codon 506 of the coagulation factor V gene
12. 34 → LeuFactor XIII polymorphism in Finnish patients with inflammatory bowel disease
13. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis
14. Detection of factor V Leiden from a drop of blood by PCR-SSCP
15. Single-nucleotide polymorphism identification assays using a thermostable DNA polymerase and delayed extraction MALDI-TOF mass spectrometry
16. High level multiplex genotyping by MALDI-TOF mass spectrometry
17. Mass spectrometry from miniaturized arrays for full comparative DNA analysis
18. Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry
19. Direct genetic analysis by matrix-assisted laser desorption/ionization mass spectrometry
20. A New MALDI-TOF based mini-sequencing assay for genotyping of SNPs
21. Incidence of venous thromboembolism in families with inherited thrombophilia
22. Phenotype and genotype expression in pseudohomozygous factor V Leiden. The need for phenotype analysis
23. Multiplex, fluorescent, solid-phase minisequencing for efficient screening of DNA sequence variation
24. A common genetic variation in the 3′-untraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
25. Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma
26. The factor V gene A4070G mutation and the risk of venous thrombosis
27. Simultaneous detection of FV Q506 and prothrombin 20210A variation by allele-specific PCR
28. Rapid simultaneous screening of factor V Leiden and G20210 prothrombin variant by multiplex polymerase chain reaction on whole blood
29. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene